MiniMed (MMED) Liabilities and Shareholders Equity (2025 - 2026)

MiniMed (MMED) posted Liabilities and Shareholders Equity of $4.7 billion for Q3 2026, up 1.9% quarter-over-quarter from $4.6 billion in Q2 2026.

Analysis

MiniMed (MMED) Liabilities and Shareholders Equity (2025 - 2026) Analysis & Trends

MiniMed (MMED) has 2 years of Liabilities and Shareholders Equity data on file, last reported at $4.7 billion in Q3 2026.

For the quarter ending Q3 2026, Liabilities and Shareholders Equity changed N/A year-over-year to $4.7 billion; the trailing twelve-month figure through Jul 2026 stood at $17.9 billion (changed N/A YoY), and the FY2026 full-year result was $4.6 billion, up 10.21% from the prior year.
Liabilities and Shareholders Equity was $4.7 billion for Q3 2026 at MiniMed, up from $4.6 billion in the prior quarter.
In the past five years, Liabilities and Shareholders Equity ranged from a high of $4.7 billion in Q3 2026 to a low of $4.2 billion in Q2 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Liabilities and Shareholders Equity (Qtr)
1	Abbott Laboratories	187.42 Bn	182.47 Bn	7.27 Bn	109.22 Bn
2	Intuitive Surgical	129.78 Bn	124.69 Bn	1.96 Bn	20.88 Bn
3	Medtronic	120.53 Bn	112.33 Bn	6.34 Bn	93.31 Bn
4	Stryker	116.28 Bn	112.80 Bn	4.50 Bn	47.93 Bn
5	Boston Scientific	69.29 Bn	68.99 Bn	3.85 Bn	45.22 Bn
6	Edwards Lifesciences	51.83 Bn	47.68 Bn	1.35 Bn	13.87 Bn
7	Alcon	34.36 Bn	32.91 Bn	1.68 Bn	31.10 Bn
8	Dexcom	33.17 Bn	31.23 Bn	830.00 Mn	6.46 Bn
9	Steris	21.90 Bn	21.43 Bn	684.20 Mn	10.74 Bn
10	MiniMed	6.55 Bn	6.34 Bn	465.00 Mn	4.72 Bn

Historic Data

Download Data